The indicative effects of apolipoproteins on organic erectile dysfunction: bridging Mendelian randomization and case-control study.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2024
Historique:
received: 20 12 2023
accepted: 24 04 2024
medline: 28 6 2024
pubmed: 28 6 2024
entrez: 28 6 2024
Statut: epublish

Résumé

The existing research on the association between apolipoproteins (Apos) and erectile dysfunction (ED) primarily relies on observational studies and does not distinguish between organic and psychogenic causes when diagnosing ED. It is difficult to believe that Apos play a role in psychogenic ED. To address these issues, our study explored the causal relationship between lipoproteins and ED using Mendelian randomization (MR) analysis and differentiate between organic and psychogenic ED through the use of nocturnal penile tumescence and rigidity (NPTR) monitoring. Multivariate MR analysis revealed significant causal associations between high-density lipoprotein (HDL), Apo A1, and Apo B/A1 with ED (OR and 95% CI were 0.33 (0.14-0.78), 3.58 (1.52-8.43), and 0.30 (0.13-0.66)). we conducted statistical and analytical analyses on the data of 212 patients using multivariate analyses and receiver operating characteristic (ROC) curves. Patients with organic ED had significantly lower levels of HDL, Apo A1 and Apo A1/B, whereas patients with organic ED had considerably higher levels of Apo B and low-density lipoprotein (LDL). The diagnostic value of Apos in predicting the risk of organic ED was evaluated using ROC curves. The results indicated that Apo A1 and Apo A1/B demonstrated good predictive value. HDL, Apo A1, and Apo A1/B have been identified as risk factors for ED in our study. Furthermore, our research highlights the significance of Apo A1 and Apo A1/Apo B in the development of organic ED and suggests their potential use as indicators to assess the risks associated with organic ED.

Identifiants

pubmed: 38938512
doi: 10.3389/fendo.2024.1359015
pmc: PMC11208309
doi:

Substances chimiques

Apolipoproteins 0
Apolipoprotein A-I 0
Lipoproteins, HDL 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1359015

Informations de copyright

Copyright © 2024 Zhang, Yan, Li, Pan, Wang, Xu, Zhou and Liu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Zhexin Zhang (Z)

Department of Urology, Xiangya Hospital, Central South University, Changsha, China.

Mo Yan (M)

Department of Urology, Xiangya Hospital, Central South University, Changsha, China.

Yuezheng Li (Y)

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Yang Pan (Y)

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Shangren Wang (S)

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Mingming Xu (M)

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Hang Zhou (H)

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Xiaoqiang Liu (X)

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH